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Summary
Introduction: Parathyroid carcinoma (PTC) is a rare parathyroid tumor. We report a case of PTC
revealed by erythema nodosum (EN).
Case study: A 53-year-old woman was admitted for EN exploration. Biology found hypercalcemia
(3mmol/L) and 184.89 ng/L parathormonemia. Histology following cervicotomy diagnosed PTC.
Postoperative course was free of complications. At eight months’ follow-up, there was no
recurrence of EN.
Discussion/conclusion: PCT is rare and life threatening. Paraneoplastic EN is rare, and has not
previously been reported in association with PCT. Solid neoplasia and hemopathy should be
systematically explored for in case of recurrent EN or resistance to conventional treatment.
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ntroduction
arathyroid carcinoma (PTC) is a rare parathyroid tumor,
t 0.5% to 4% of cases of primary hyperparathyroidism
HPT) [1,2]. Diagnosis is difﬁcult and generally late. Almost
00 cases have been published. The carcinoma is revealed
y cervical tumefaction or signs relating to hypercalcemia
Hca) in respectively 65% and 59% of cases, and otherwise
y dysphonia, bone pain (40%) or serendipitously (18%). Ery-
hema nodosum (EN) is in rare cases paraneoplastic.∗ Corresponding author.
E-mail address: hamzaoui.amira@yahoo.fr (A. Hamzaoui).
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ase study
53-year-old woman was admitted for EN exploration.
nterview revealed similar episodes with six months’ evo-
ution, associated with 3 kg weight-loss and asthenia.
hysical examination found EN, conﬁrmed on cutaneous
iopsy (Fig. 1). Biology found normal complete blood count
leukocytes 6000 elt/mm3, Hb 13 g/dL, platelets 350,000
lt/mm3), erythrocyte sedimentation rate 50mmH1, Hca
mmol/L, hyperchloremia 115mmol/L and hyperparathor-
onemia (PTH) 184.89 ng/L. Serum protein electrophoresis
nd liver and kidney assessment were normal. ECG found 2nd
egree atrioventricular block, supraventricular extrasys-
oles and shortening of the QT space. There was no
one impact. On initial etiological assessment, tuberculosis
ssessment (tuberculin intradermal reaction, Mycobac-
erium tuberculosis test in sputum and urine, and gastric
served.
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(Figure 1 a: tumor with microglandular architecture and en
(HE× 100); c: intravascular tumoral embolus (HE× 400).
intubation), tumor marker assay (CA-125, CA-15.3, ACE,
FP, CA 19.9) and angiotensin conversion enzyme assay
were all normal. Accessory salivary gland biopsy found mild
Chisholm grade-1 chronic sialadenitis. Gynecological exami-
nation with cervico-vaginal swab, abdominal ultrasound and
thoraco-abdomino-pelvic CT, respiratory function test and
ophthalmic examination were normal. Cervical ultrasound
found a 1.7× 1.3 cm left parathyroid nodule pushing back
the left thyroid lobe, with multiple bilateral jugulo-carotid
adenopathies. Sestamibi parathyroid scintigraphy found a
left inferior area of polar activity suggestive of left parathy-
roid adenoma.
The patient underwent hyperhydration with 0.9% isotonic
saline and furosemide 20mg (Lasilix®) at 120mg/24 hrs.
Left cervical exploration under general anaesthesia, with
Kocher incision and subcutaneous release, found a blackish
formation at the inferior pole of the left thyroid lobe, of 3 cm
along the main axis, adhering to the gland and to the recur-
rent nerve. Left lobo-isthmectomy with ipsilateral recurrent
curage was performed. Deﬁnitive histopathology diagnosed
a left inferior parathyroid carcinoma of 2.5 cm along the
main axis, inﬁltrating the parathyroid tissue; the parathy-
roid gland comprised regular cells without atypical nuclei
or mitoses, covering the gland structures or forming small
clusters separated by large zones of hemorrhagic suffusion,
located within the parathyroid capsule and in the vessel
lumens, with images of intravascular tumoral emboli; there
were no lymph-node metastases (ON+/1N) (Fig. 2). Post-
operative course was free of complications, with 9.98 ng/L
PTH at day-1, and normalized calcemia at day-2. At eight
months’ follow-up, there was no recurrence of EN.
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tinoid stroma (HE× 40); b: capsule inﬁltration by tumor cells
iscussion
TC is a rare parathyroid tumor characterized by local
evelopment with invasion of neighbouring tissue [3]. Mean
ge at discovery is 54.5 years, with a lower female predom-
nance than found in primary HPT, at 1.3. Biologic analysis
s characterized by severe Hca, at more than 3.5mmol/L in
5—75% of cases. PTH levels are generally ten times as high
s normal; some authors consider PTC highly improbable in
ase of PTH less than 4 times the normal. Non-secreting PTC
an exist [4].
Peroperative and histological ﬁndings are essential.
urgery is based on monoblock removal, conserving the
apsule in order to prevent local recurrence, tumor exere-
is and ablation of the ipsilateral thyroid lobe, ipsilateral
arathyroid and ipsilateral pre-tracheal, recurrent and in
ome cases jugulo-carotid lymph-node chains. Lymph-node
etastasis is found in 25% of cases and impacts progno-
is. Adapted surgery is the reference attitude; adjuvant
reatments (external radiation therapy or chemotherapy)
re relatively ineffective. Local and metastatic recurrence
lung, liver and bone), however, occurs in 25—60% of cases
ithin two to ﬁve years. Survivorship is dependent on Hca
evels [5].
EN is clinically the most frequent form of panniculitis
nd may by idiopathic or secondary to various etiologies
medication, infection, systemic, etc.). Cutaneous biopsy
s not essential to diagnosis of EN. Associated EN and neo-
lasia has been reported, but is rare [6]. Some 50 cases of
N are to be found in the literature: malignant hemopa-
hy [7] (Hodgkin or malignant non-Hodgkin lymphoma,
274 A. Hamzaoui et al.
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[9] Lin JT, Chen PM, Huang DF, et al. Erythema nodosum associatedigure 2 a: erythema nodosum: septal hypodensity with thic
cute myeloid leukaemia, tricholeukocyte leukaemia, etc.),
enerally, associated with extended forms, or, more rarely,
olid neoplasms (colon, pancreas, hepatocellular carcinoma,
tomach, kidney, neck of the uterus, etc.) [8—10].
EN may thus precede the neoplasia by several months
r years, or reveal it. Absence of other possible causes of
N and regression of skin lesions under anticancer therapy
uggest a causal link. The morphology, histologic type and
istribution of skin lesions are similar in both paraneoplas-
ic EN and EN of other or idiopathic etiology; it is, however,
ssociated with poor response to conventional treatment
anti-inﬂammatory, potassium iodide) [10].
onclusion
TC is rare but life threatening. Revelation by EN, as in
he present case, may exceptionally occur; even so, explo-
ation for EN is not mandatory in case of PTC. Exploration
or solid neoplasms or hemopathy in case of recurrent EN or
esistance to conventional treatment should, however, be
ystematic.isclosure of interest
he authors declare that they have no conﬂicts of interest
oncerning this article.
[d, ﬁbrous, inﬂammatory septa; b: lymphocyte vascularity.
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